Navigation Links
Thailand Will Not Issue Compulsory Licenses for Patented Drugs

Thai Health Minister Mongkol Na Songkhla on Tuesday said that Thailand will not issue compulsory licenses to produce reduced-cost versions of patented drugs if pharmaceutical companies offer prices lower than those charged by generic drug makers, Reuters AlertNet reports. Mongkol's comments came one day after Abbott Laboratories and Thailand failed to reach an agreement on the price of Abbott's antiretroviral drugs Aluvia and Kaletra.

The Thai government in November 2006 and January issued compulsory licenses to produce lower-cost versions of Merck's antiretroviral Efavirenz and Kaletra, respectively. Since then, the government and drug companies have continued negotiations. Abbott earlier this week offered to sell Aluvia at a reduced price in Thailand on the condition that the country agrees not to allow generic versions of the drug into the market, Siriwat Thiptaradol, secretary-general of Thailand's Food and Drug Administration, said.

Abbott offered to sell Aluvia for about 34,000 baht, or $1,000, per person annually. Indian generic drug maker Matrix Laboratories has offered to sell a generic version of Aluvia to Thailand for 24,324 baht, or $695, per person annually. Siriwat said that the offer would be considered by Mongkol.

Under the terms of the offer, Thailand would have to agree not to seek compulsory licensing for Aluvia and the price of Aluvia could not be reduced any further. According to Reuters Alertnet, Aluvia is needed in Thailand because it is a heat-stable version of Kaletra and eliminates the need for costly refrigeration.

Mongkol said that compulsory licenses are needed "to make the drugs affordable for all, not for commercial purposes." The health ministry's decision to reject Abbott's offer was praised by some HIV/AIDS advocates. Jon Ungphakorn, secretary-general of Thailand's AIDS Access Foundation, said Abbott's offer demonstrates that the company "never treated patients as human beings , but business." He urged the ministry to refrain from holding further negotiations with Abbott unless the company seeks to introduce new drugs in the country.


Related medicine news :

1. Thailand had Fewer AIDS-Related Deaths, New HIV Cases In 2005
2. Botulism Scare in Thailand Shakes US
3. Thailand To Procure Botulism Antitoxin Internationally
4. Thailand To Test Efficacy Of Stem Cell Technology
5. Thailand to Explore Stem Cell Technology for Treatment of Heart Disease
6. People In Thailand Not Bothered About Bird Flu
7. Thailand Tops in Rare Type of Cancer
8. Bird Flu in Thailand Suspected to be H5N1 Strain
9. Forty-Six Suspected Bird Flu Cases In Thailand
10. Screening of bird flu patients by pharmacies in Thailand
11. Thailand May Seek Help Of Pharmacies For Screening Bird Flu
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... In honor of Pulmonary Hypertension ... and groups responsible for advancing care for pulmonary hypertension (PH) patients and helping ... public, will receive special recognition throughout 2016 as part of PHA’s 25th anniversary ...
(Date:11/25/2015)... ... 25, 2015 , ... Bcureful—a non-profit organization devoted to advancing ... public awareness of the disorder while helping to bring expert medical care and ... bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert H. ...
(Date:11/24/2015)... ... 2015 , ... Eric C. Seidel, DMD and Stephanie DeFilippo, ... revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology uses light energy ... dentist in Gettysburg, PA . From routine visits to cosmetic treatments, laser dentistry ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... ... ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, Dec. ... has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls under ... the device regulations. , Come up short in an inspection and the FDA can ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... 2015 Developmental, commercial, and regulatory/legal ... profitability of pharmaceutical products, says GBI Research ... regulatory/legal strategies all play a key role in boosting ... . --> Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ...
(Date:11/25/2015)... Research and Markets ( ) has ... Global Forecast to 2020" report to their offering. ... 37.21% of the total market share in 2014. The ... is projected to growth at the highest CAGR between ... to the fast growing water, industrial gas treatment, pharmaceutical, ...
Breaking Medicine Technology: